The Wire · Case news
Court rulings, settlements, and case developments, with links to the source records.
Roblox Child Exploitation
According to a report by Hoodline, which cites Consumer Notice, lawsuits alleging that Roblox failed to protect children from online grooming have been consolidated into federal multidistrict litigation in the Northern District of California.
Source: hoodline.com
CPAP Cancer
Philips Respironics recalled certain masks used with its CPAP and BiPAP machines after a medical device report listed 14 serious injuries and no deaths tied to the masks, according to NeurologyLive.
Source: neurologylive.com
Bard PowerPort Catheter
The federal judge overseeing the Bard PowerPort multidistrict litigation in Arizona denied a motion for summary judgment filed by C.R. Bard Inc. and Becton Dickinson and Co., allowing a woman's design-defect claims to proceed to the third bellwether trial in the MDL, according to Mealey's and Bloomberg Law.
Source: mealeys.com
Roundup lawsuit: who may qualify and what happens next
Attorneys for three cancer patients began presenting their case to a Missouri jury on September 29, 2026, arguing Bayer's Monsanto unit failed to adequately test Roundup before selling it. The trial comes as nearly 4,000 Roundup actions remain pending in federal multidistrict litigation and the EPA continues its glyphosate review.
Source: insurancejournal.com
AFFF Firefighting Foam
A federal judge in South Carolina denied a motion asking him to reconsider his earlier partial denial of a joint request to remand nine water utility lawsuits in the AFFF multidistrict litigation back to state court, according to Mealey's. The utilities had accused DuPont de Nemours Inc. and EIDP Inc., among others, of PFAS contamination.
Source: mealeys.com
Wrongful Death Lawsuit
Rebecca Good, Renee Good's partner, and Brent Ganger, trustee for Good's next of kin, filed two lawsuits in the U.S. District Court for the District of Minnesota over Good's fatal encounter with federal immigration enforcement. A separate report identified the officer involved as Jonathan Ross and referenced video from the scene.
Source: freerepublic.com
GLP-1 Vision Loss (Ozempic / Wegovy NAION)
News outlets reported that over 200 federal lawsuits have been filed alleging GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro caused NAION, a rare and often permanent form of vision loss. Manufacturers reportedly dispute the claims, and plaintiffs allege they were not adequately warned of the risk.
Source: yahoo.com
Nursing Home Abuse & Elder Abuse
KFF Health News and NPR reported that long-term care facilities continue to use potent sedating medications on agitated dementia patients, despite federal efforts to discourage the practice. The reporting centers on a Michigan case illustrating disputes between families and guardians over such treatment decisions.
Source: kffhealthnews.org
AFFF Firefighting Foam
According to The Cool Down, several New Hampshire towns sued 3M and DuPont, alleging PFAS chemicals in firefighter protective gear exposed firefighters to cancer risk. Separately, WBOC reported that Salisbury, Maryland residents are seeking to add firefighting foam companies to an existing PFAS lawsuit against Perdue.
Source: news.google.com
Ozempic / GLP-1 Lawsuits
According to a report from MedShadow Foundation, the FDA issued a warning that some GLP-1 receptor agonist pens may contain no medication. The report was published alongside separate coverage of ongoing gastroparesis litigation and new peer-reviewed research examining GLP-1 drugs and bipolar disorder hospitalization, pregnancy complications, and orofacial adverse events.
Source: news.google.com
Wrongful Death Lawsuit
The East Bay Regional Parks District reached a settlement with the family of a man who was tased by officers and left comatose. Attorneys involved did not confirm specific settlement terms and said a joint press release was planned, according to KQED.
Source: kqed.org
GLP-1 Vision Loss (Ozempic / Wegovy NAION)
The New York Post reported that a man's claim of sudden, permanent blindness after using Ozempic is one of hundreds of lawsuits filed against GLP-1 drug makers alleging inadequate warning of vision loss risk. Separately, a Medical Economics roundup noted reporting that Wegovy may carry a higher risk of 'eye stroke' than other GLP-1 drugs, and a systematic review in the Canadian Journal of Ophthalmology examined a possible link between GLP-1 receptor agonist use and age-related macular degeneration.
Source: news.google.com